Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2010 | 08-2010 | 05-2010 | 02-2010 | 11-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,132 | 67,202 | 58,763 | 37,513 | 36,256 |
| Marketable Securities | 83,471 | 34,796 | 41,311 | 48,265 | 37,772 |
| Receivables | 25,762 | 23,637 | 29,838 | 26,536 | 25,397 |
| Inventories | 32,731 | 33,517 | 29,216 | 34,115 | 39,874 |
| Income taxes - deferred | 2,997 | 4,234 | 5,281 | 6,049 | 7,283 |
| TOTAL | $177,446 | $169,782 | $171,360 | $158,351 | $151,627 |
| Non-Current Assets | |||||
| PPE Net | 24,102 | 24,092 | 24,193 | 23,293 | 22,600 |
| Intangibles | 215,912 | 218,067 | 220,326 | 222,712 | 225,007 |
| Other Non-Current Assets | 8,523 | 8,410 | 8,046 | 7,939 | 8,399 |
| TOTAL | $248,537 | $250,569 | $252,565 | $253,944 | $256,006 |
| Total Assets | $425,983 | $420,351 | $423,925 | $412,295 | $407,633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 270 | 260 | 260 | 255 | 250 |
| Accounts payable and accrued liabilities | 8,056 | 8,758 | 12,044 | 8,640 | 8,692 |
| Accrued Expenses | 11,795 | 9,413 | 13,722 | 9,875 | 11,229 |
| Other current liabilities | N/A | N/A | N/A | N/A | 43 |
| TOTAL | $20,121 | $18,431 | $26,026 | $18,770 | $20,214 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,410 | 6,485 | 6,550 | 6,615 | 6,680 |
| TOTAL | $6,410 | $6,485 | $6,550 | $6,615 | $6,680 |
| Total Liabilities | $26,531 | $24,916 | $32,576 | $25,385 | $26,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,943 | 24,913 | 24,754 | 24,727 | 24,557 |
| Common Shares | 248 | 248 | 247 | 247 | 246 |
| Retained earnings | 32,319 | 29,040 | 27,152 | 23,413 | 20,080 |
| Other shareholders' equity | -1,402 | -1,275 | -1,394 | -1,223 | -1,015 |
| TOTAL | $399,452 | $395,435 | $391,349 | $386,910 | $380,739 |
| Total Liabilities And Equity | $425,983 | $420,351 | $423,925 | $412,295 | $407,633 |